Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
Khairuddin Memon(Northwestern University), Riad Salem(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Mary F. Mulcahy(Northwestern University), Paul Nikolaidis(Northwestern University), Reed A. Omary(Vanderbilt University), Robert K. Ryu(University of Colorado Anschutz Medical Campus), Michaël Abécassis(University of Arizona), Vahid Yaghmai(Virginia Commonwealth University Medical Center), Ahsun Riaz(Northwestern University), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Talia Baker(University of Utah), Edward Wang, Al B. Benson(Northwestern University)
Cited by 95
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k